Serum Peptidome Variations in a Healthy Population: Reference to Identify Cancer-Specific Peptides

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  He, Kun ^a   Wen, Xin Yu ^b   Li, Ai Ling ^a   Li, Tao ^a   Wang, Jie ^a   Wang, Hong Xia ^a   Wang, Na ^a  

^a NATIONAL CENTER OF BIOMEDICAL ANALYSIS   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; EXOPEPTIDASE;

ADULT; AMINO ACID SEQUENCE; ARTICLE; BREAST CANCER; CANCER PATIENT; CONTROLLED STUDY; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PEPTIDE ANALYSIS; PEPTIDOMICS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RECTUM CANCER; TANDEM MASS SPECTROMETRY;

AGE FACTORS; BREAST NEOPLASMS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HEALTHY VOLUNTEERS; HUMANS; LUNG NEOPLASMS; MALE; MASS SPECTROMETRY; PEPTIDES; RECTAL NEOPLASMS; REFERENCE VALUES; SEX FACTORS;

EID: 84877267585     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063724     Document Type: Article

References (27)

1. Petricoin EF, Belluco C, Araujo RP, Liotta LA, (2006) The blood peptidome: a higher dimension of information content for cancer biomarker discovery. Nature 6: 961-967.
2. Villanueva J, Shaffer DR, Philip J, Chaparro CA, Bromage HE, et al. (2006) Differential exoprotease activities confer tumor-specific serum peptidome patterns. J Clin Investig 116: 271-284.
3. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, et al. (2002) Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359: 572-577.
4. Ho DW, Yang ZF, Wong BY, Kwong DL, Sham JS, et al. (2006) Surface-enhanced laser desorption/ionization time of flight mass spectrometry serum protein profiling to identify nasopharyngeal carcinoma. Cancer 107: 99-107.
5. Ward DG, Suggett N, Cheng Y, Wei W, Johnson H, et al. (2006) Identification of serum biomarkers for colon cancer by proteomic analysis. Br J Cancer 94: 1898-1905.
6. Soltys SG, Le QT, Shi G, Tibshirani R, Giaccia AJ, et al. (2004) The use of plasma surface-enhanced laser desorption/ionization time-of -flight mass spectrometry proteomic patterns for detection of head and neck squamous cell cancers. Clin Cancer Res 10: 4806-4812.
7. Koopmann J, Zhang Z, White N, Rosenzweig J, Fedarko N, et al. (2004) Serum diagnosis of pancreatic adenocarcinoma using surface-enhanced laser desorption and ionization mass spectrometry. Clin Cancer Res 10: 860-868.
8. Li J, Zhang Z, Rosenzweig J, Wang YY, Chan DW, (2002) Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin Chem 48: 1296-1304.
9. Agranoff D, Fernandez-Reyes D, Papadopoulos MC, Rojas SA, Herbster M, et al. (2006) Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum. Lancet 368: 1012-1021.
10. Liang T, Wang N, Li W, Li A, Wang J, et al. (2010) Identification of complement C3f-desArg and its derivative for acute leukemia diagnosis and minimal residual disease assessment. Proteomics 10: 90-98.
11. Wu J, Wang N, Wang J, Xie Y, Li Y, et al. (2010) Identification of a uromodulin fragment for diagnosis of IgA nephropathy. Rapid Commun Mass Spectrom 24: 1971-1978.
12. Dekker LJ, Boogerd W, Stockhammer G, Dalebout JC, Siccama I, et al. (2005) MALDI-TOF mass spectrometry analysis of cerebrospinal fluid tryptic peptide profiles to diagnose leptomeningeal metastases in patients with breast cancer. Mol Cell Proteomics 4: 1341-1349.
13. Colquhoun DR, Schwab KJ, Cole RN, Halden RU, (2006) Detection of norovirus capsid protein in authentic standards and in stool extracts by matrix-assisted laser desorption ionization and nanospray mass spectrometry. Applied and Environmental Microbiology 72: 2749-2755.
14. Cheng AJ, Chen LC, Chien KY, Chen YJ, Chang JT, et al. (2005) Oral cancer plasma tumor marker identified with bead-based affinity-fractionated proteomic technology. Clin Chem 51: 2236-2244.
15. Koomen JM, Shih LN, Coombes KR, Li D, Xiao LC, et al. (2005) Plasma protein profiling for diagnosis of pancreatic cancer reveals the presence of host response proteins. Clin Cancer Res 11: 1110-1118.
16. Mian S, Ugurel S, Parkinson E, Schlenzka I, Dryden I, et al. (2005) Serum proteomic fingerprinting discriminates between clinical stages and predicts disease progression in melanoma patients. J Clin Oncol 23: 5088-5093.
17. Coon JJ, Syka JE, Shabanowitz J, Hunt DF (2005) Tandem mass spectrometry for peptide and protein sequence analysis. Biotechniques 38: 519, 521, 523.
18. Villanueva J, Philip J, Entenberg D, Chaparro CA, Tanwar MK, et al. (2004) Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry. Anal Chem 76: 1560-1570.
19. Baumann S, Ceglarek U, Fiedler GM, Lembcke J, Leichtle A, et al. (2005) Standardized approach to proteome profiling of human serum based on magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chem 51: 973-980.
20. Villanueva J, Martorella AJ, Lawlor K, Philip J, Fleisher M, et al. (2006) Serum peptidome patterns that distinguish metastatic thyroid carcinoma from cancer-free controls are unbiased by gender and age. Mol Cell Proteomics 5: 1840-1852.
21. Wang N, Dong FT, Zhang XM, Li AL, Wang J, et al. (2007) Hydrothermal Synthesis of Metal-Chelated Magnetic Nanobeads for Exclusive Use of Peptides Extraction by Mass Spectrum. Acta Chimica Sinica 65: 344-348.
22. Nedelkov D, Kiernan UA, Niederkofler EE, Tubbs KA, Nelson RW, (2006) Population proteomics: the concept, attributes, and potential for cancer biomarker research. Mol Cell Proteomics 5: 1811-1818.
23. Semmes OJ, Feng Z, Adam BL, Banez LL, Bigbee WL, et al. (2005) Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility. Clin Chem 51: 102-112.
24. Novak K, (2006) Biomarkers:Taking out the trash. Nature 6: 92.
25. Honda K, Hayashida Y, Umaki T, Okusaka T, Kosuge T, et al. (2005) Possible detection of pancreatic cancer by plasma protein profiling. Cancer Res 65: 10613-10622.
26. Bergquist J, Palmblad M, Wetterhall M, Hakansson P, Markides KE, (2002) Peptide mapping of proteins in human body fluids using electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry. Mass Spectrom Rev 21: 2-15.
27. Johnson KL, Mason CJ, Muddiman DC, Eckel JE, (2004) Analysis of the low molecular weight fraction of serum by LC-Dual ESI-FT-ICR mass spectrometry: Precision of retention time, mass, and ion abundance. Anal Chem 76: 5097-5103.